Seeking Alpha
Long/short equity, contrarian, short-term horizon, dividend investing
Profile| Send Message|
( followers)  

This is Part V of earnings being reported on Tuesday. There are quite a few market moving stocks reporting earnings. It is not hard to tell we are right in the middle of earnings season. Due to the quantity of companies reporting I am focusing on the highest volume traded stocks. It is easy to see we are in the middle of earnings season when it takes this many parts to go over the biggest companies reporting in one day.

Linear Technology Corp. (LLTC) is a $7.12 billion market cap company. Linear Technology designs, manufactures and markets a broad line of standard high performance linear integrated circuits.
The company reported (basic) $0.61 per share in earnings for the quarter ending April 3, 2011. The Quick Ratio is 2.08. The next reporting quarter estimated mean earnings are $0.56 per share. Analyst estimates range between $0.54 and $0.59 per share.

Click to enlarge

The current trailing twelve months (ttm) P/E ratio is 13.25 and the forward P/E ratio is 13.19. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 166.36. The price to sales ratio is 5.66. This is another rare company that appears to be doing better than the stock price may suggest. I am going to look further into this company and possibly write up an article, if I find a compelling reason to move forward on an investment.

In the last month the stock has moved in price 21.72%, with a one year change of 24.97%. Comparing to the S&P 500 price change, Linear Technology's performance is 3.02% vs. the S&P 500 from a month ago, and the one year difference is 3.69% vs. S&P 500 price change.


The annual growth rate of revenue is 20.8%. The last fiscal year had accounts receivable to sales percentage of 0.1512% compared to the same period a year earlier of 0.0985%. For the trailing twelve months investors received $0.9 in dividends for a yield of 3.07%.


Linear Technology has rising revenue year-over-year of $1.17 billion for 2010 vs. $968.50 million for 2009. The bottom line has rising earnings year-over-year of $361.34 million for 2010 vs. $289.21 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $563.41 million for 2010 vs. $412.08 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.56 0.62 0.06 10.38%
Dec-10 0.58 0.64 0.06 9.72%
Sep-10 0.62 0.62 0 0.00%
Jun-10 0.51 0.59 0.08 15.14%
Mar-10 0.39 0.46 0.07 18.74%

Amylin Pharmaceuticals Inc (AMLN) is a $1.99 billion market cap biopharmaceutical company engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Its wholly owned subsidiaries are Amylin Ohio, LLC, and Amylin Investments, LLC.
The company reported (basic) $0.26 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 1.39.

The stock has a price to book ratio (ttm) of 6.15. The price to sales ratio is 3.16. The Friday's closing price puts the stock price right at the 200 day moving average. Last week was also a very strong week moving the price off a recent dip. Another dip would indicate a very nice buying signal, as I would expect another retest of the moving average.

In the last month the stock has moved in price -14.94%, with a one year change of -18.52%. Comparing to the S&P 500 price change, Amylin's performance is 9.47% vs. the S&P 500 from a month ago, and the one year difference is 12.29% vs. S&P 500 price change.

The annual growth rate of revenue is -11.81%. The last fiscal year had accounts receivable to sales percentage of 0.0817% compared to the same period a year earlier of 0.0801%.
Amylin has falling revenue year-over-year of $668.81 million for 2010 vs. $758.42 million for 2009. The bottom line has rising earnings year-over-year of $-152.31 million for 2010 vs. $-186.26 million for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $-126.74 million for 2010 vs. $-173.35 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 -0.23 -0.26 -0.03 NA%
Dec-10 -0.32 -0.13 0.19 NA%
Sep-10 -0.35 -0.35 0 NA%
Jun-10 -0.29 -0.31 -0.02 NA%
Mar-10 -0.28 -0.27 0.01 NA%

Manitowoc Co Inc. (MTW) is a $2.11 billion market cap multi-industry, capital goods manufacturer. It operates in two markets: Cranes and Related Products (Crane) and Foodservice Equipment (Foodservice). Crane is the provider of engineered lifting equipment for the global construction industry, including lattice-boom cranes, tower cranes, mobile telescopic cranes, and boom trucks. Foodservice is a manufacturer of commercial foodservice equipment serving the ice, beverage, refrigeration, food-preparation, and cooking needs of restaurants, convenience stores, hotels, healthcare, and institutional applications.

The company reported (basic) $0.4 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 0.59. The next reporting quarter estimated mean earnings are $0.18 per share. Analyst estimates range between $0.13 and $0.23 per share.

The forward P/E ratio is 11.26. The stock has a price to book ratio (ttm) of 3.57. The price to sales ratio is 0.55.

In the last month the stock has moved in price 4.24%, with a one year change of 57.23%. Comparing to the S&P 500 price change, Manitowoc's performance is -1.7% vs. the S&P 500 from a month ago, and the one year difference is 27.85% vs. S&P 500 price change.

The annual growth rate of revenue is -13.21%. The last fiscal year had accounts receivable to sales percentage of 0.0812% compared to the same period a year earlier of 0.0814%. For the trailing twelve months investors received $0.08 in dividends for a yield of 0.5%.

Manitowoc has falling revenue year-over-year of $3.14 billion for 2010 vs. $3.62 billion for 2009. The bottom line has rising earnings year-over-year of $-73.40 million for 2010 vs. $-704.20 million for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $206.50 million for 2010 vs. $-512.40 million for 2009. The stock is trading near the 200 day moving average and appears to be more likely to move below it then move higher. I would be looking to short this one before buying it.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.04 -0.1 -0.14 NA%
Dec-10 0.04 0.11 0.07 203.03%
Sep-10 0.11 0.01 -0.1 -91.17%
Jun-10 0.06 0.12 0.06 89.87%
Mar-10 -0.02 -0.08 -0.06 NA%

Biogen Idec Inc. (BIIB) is a $25.51 billion market cap global biotechnology company focused on discovering, developing, manufacturing and marketing products for the treatment of neurological disorders and other serious diseases. The company’s products include AVONEX, TYSABRI, FUMADERM and RITUXAN.
The company reported (basic) $1.22 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 2.14. The next reporting quarter estimated mean earnings are $1.38 per share. Analyst estimates range between $1.23 and $1.53 per share.

The current trailing twelve months (ttm) P/E ratio is 24.323 and the forward P/E ratio is 16.92. The stock has a price to book ratio (ttm) of 3.17. The price to sales ratio is 3.62.

In the last month the stock has moved in price 8.15%, with a one year change of 9.32%. Comparing to the S&P500 price change, Biogen Idec Inc.'s performance is 1.69% vs. the S&P 500 from a month ago, and the one year difference is 1.99% vs. S&P 500 price change. The charts look great, but almost too great. I would be concerned after the recent run up, if the market does not like the report, the stock may be sold off hard and fast. Selling some call options and or buying some protective put options would appear to be worth looking into.

The annual growth rate of revenue is 7.75%. The last fiscal year had accounts receivable to sales percentage of 0.1283% compared to the same period a year earlier of 0.1259%.
Biogen Idec Inc. has rising revenue year-over-year of $4.72 billion for 2010 vs. $4.38 billion for 2009. The bottom line has rising earnings year-over-year of $1.01 billion for 2010 vs. $970.13 million for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $1.25 billion for 2010 vs. $1.30 billion for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 1.41 1.43 0.02 1.32%
Dec-10 1.23 1.42 0.19 15.53%
Sep-10 1.22 1.35 0.13 10.25%
Jun-10 1.12 1.31 0.19 17.47%
Mar-10 1.13 1.08 -0.05 -4.38%

Norfolk Southern Corp (NSC) is a $26.92 billion market cap Virginia based company that controls a railroad, Norfolk Southern Railway Company. Norfolk Southern Railway Company is primarily engaged in the rail transportation of raw materials, intermediate products, and finished goods primarily in the Southeast, East, and Midwest and, via interchange with rail carriers to and from the rest of the United States. It also transports overseas freight through several Atlantic and Gulf Coast ports.
The company reported (basic) $0.91 per share in earnings for the quarter ending March 31, 2011. The Quick Ratio is 1.11. The next reporting quarter estimated mean earnings are $1.29 per share. Analyst estimates range between $1.2 and $1.36 per share.

The current trailing twelve months (ttm) P/E ratio is 18.059 and the forward P/E ratio is 13.42. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 2.2. The price to sales ratio is 2.47.

In the last month the stock has moved in price 6.33%, with a one year change of 39.27%. Comparing to the S&P500 price change, Norfolk Southern Corp's performance is 0.27% vs. the S&P 500 from a month ago, and the one year difference is 13.25% vs. S&P 500 price change.

The annual growth rate of revenue is 19.41%. The last fiscal year had accounts receivable to sales percentage of 0.0848% compared to the same period a year earlier of 0.0961%. For the trailing twelve months investors received $1.39 in dividends for a yield of 2.1%.


Norfolk Southern Corp has rising revenue year-over-year of $9.52 billion for 2010 vs. $7.97 billion for 2009. The bottom line has rising earnings year-over-year of $1.50 billion for 2010 vs. $1.03 billion for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $2.68 billion for 2010 vs. $1.96 billion for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.90 1 0.1 10.71%
Dec-10 1.05 1 -0.05 -4.53%
Sep-10 1.09 1.19 0.1 8.85%
Jun-10 0.99 1.04 0.05 5.28%
Mar-10 0.68 0.61 -0.07 -9.79%

Price T Rowe Group Inc (TROW) is a $15.67 billion market cap financial services holding company. It provides investment advisory services to individual and institutional investors in the sponsored T. Rowe Price mutual funds and other investment portfolios.
The company reported (basic) $0.75 per share in earnings for the quarter ending March 31, 2011. The next reporting quarter estimated mean earnings are $0.78 per share. Analyst estimates range between $0.76 and $0.79 per share.

The current trailing twelve months (ttm) P/E ratio is 22.507 and the forward P/E ratio is 16.35. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 5.2. The price to sales ratio is 7.24.

In the last month the stock has moved in price 18.71%, with a one year change of 21.12%. Comparing to the S&P 500 price change, Price T Rowe Group Inc's performance is 7.06% vs. the S&P 500 from a month ago, and the one year difference is 8.66% vs. S&P 500 price change.

The annual growth rate of revenue is 26.76%. The last fiscal year had accounts receivable to sales percentage of 0.1301% compared to the same period a year earlier of 0.1318%. For the trailing twelve months investors received $1.05 in dividends for a yield of 2.06%. The stock is off the recent lows and may make another run for the 200 day moving average. The 60 day and 90 day moving averages are falling fast and have crossed down below the 200 day recently. This one could get very active during the day attracting many traders.


Price T Rowe Group Inc has rising revenue year-over-year of $2.37 billion for 2010 vs. $1.87 billion for 2009. The bottom line has rising earnings year-over-year of $672.20 million for 2010 vs. $433.60 million for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.75 0.72 -0.03 -4.31%
Dec-10 0.69 0.72 0.03 4.73%
Sep-10 0.60 0.64 0.04 6.7%
Jun-10 0.60 0.59 -0.01 -2.24%
Mar-10 0.58 0.57 -0.01 -2.3%

Lockheed Martin Corp (LMT) is a $27.65 billion market cap global security company engaged in the research, design, development, manufacture, integration, and sustainment of advanced technology systems and products. The company also provides a range of management, engineering, technical, scientific, logistic, and information services.
The company reported (basic) $1.52 per share in earnings for the quarter ending March 27, 2011. The Quick Ratio is 0.94. The next reporting quarter estimated mean earnings are $1.94 per share. Analyst estimates range between $1.78 and $2.04 per share.

The current trailing twelve months (ttm) P/E ratio is 10.83 and the forward P/E ratio is 9.13. The falling P/E ratio is the result of future earnings increasing relative to the current price and suggests bullishness in the company by analysts. The stock has a price to book ratio (ttm) of 6.95. The price to sales ratio is 0.56.

In the last month the stock has moved in price 0.51%, with a one year change of 7.21%. Comparing to the S&P 500 price change, Lockheed Martin Corp's performance is -5.22% vs. the S&P 500 from a month ago, and the one year difference is -12.82% vs. S&P 500 price change. While the stock may be trailing the overall market, the chart still looks reasonable. With the military industrial complex that America has continued to fund over the years, it is difficult to imagine that we are about to become "peace loving" any time soon. Investors considering Lockheed may be well advised to keep one eye on the stock price, and one eye on the budget issues/debt limit debate.

The annual growth rate of revenue is 4.11%. The last fiscal year had accounts receivable to sales percentage of 0.1257% compared to the same period a year earlier of 0.1378%. For the trailing twelve months investors received $2.67 in dividends for a yield of 3.77%.

Lockheed Martin Corp. has rising revenue year-over-year of $45.80 billion for 2010 vs. $44.00 billion for 2009. The bottom line has falling earnings year-over-year of $2.93 billion for 2010 vs. $3.02 billion for 2009. The company's earnings before income and taxes are falling with an EBIT year-over-year of $4.10 billion for 2010 vs. $4.42 billion for 2009.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 1.51 1.55 0.04 2.81%
Dec-10 2.11 2.3 0.19 9.12%
Sep-10 1.53 1.55 0.02 1.29%
Jun-10 1.78 1.96 0.18 10.09%
Mar-10 1.39 1.45 0.06 4.44%

Ace Ltd (ACE) is a $22.19 billion market cap holding company of the ACE Group of Companies. ACE is a global insurance and reinsurance organization, serving the needs of commercial and individual customers in more than 170 countries.
The company reported (basic) $0.77 per share in earnings for the quarter ending March 31, 2011. The next reporting quarter estimated mean earnings are $1.69 per share. Analyst estimates range between $1.26 and $1.92 per share.

The current trailing twelve months (ttm) P/E ratio is 8.599 and the forward P/E ratio is 8.89. A rising P/E ratio is usually not what we want to see for an investment. The stock has a price to book ratio (ttm) of 0.92. The price to sales ratio is 1.33.

In the last month the stock has moved in price 2.86%, with a one year change of 24.32%. Comparing to the S&P500 price change, Ace Ltd's performance is -3% vs. the S&P 500 from a month ago, and the one year difference is 1.09% vs. S&P 500 price change.

The annual growth rate of revenue is 6.18%. For the trailing twelve months investors received $1.27 in dividends for a yield of 2.13%.

Ace Ltd. has rising revenue year-over-year of $16.01 billion for 2010 vs. $15.08 billion for 2009. The bottom line has rising earnings year-over-year of $3.11 billion for 2010 vs. $2.55 billion for 2009. The company's earnings before income and taxes are rising with an EBIT year-over-year of $3.67 billion for 2010 vs. $3.08 billion for 2009. The stock recently bounced off of the 200 day moving average, but appears to be under some pressure.

Here is a look at reported earnings (some one time items are often excluded in reported EPS) compared to the mean estimate. Dollar differences are rounded to the nearest penny and percentage differences are rounded based on rounded dollar differences.

Fiscal Quarter Ending Month-YR Estimate Actual Difference Difference %
Mar-11 0.62 0.79 0.17 26.95%
Dec-10 1.85 2.05 0.2 11.1%
Sep-10 1.86 2.01 0.15 7.86%
Jun-10 1.83 2.01 0.18 9.72%
Mar-10 1.65 1.7 0.05 2.79%
Source: 8 Companies to Consider That Are Reporting Earnings on Tuesday, Part V